Skip to content

Evaluation of a telemedicine approach in the care of patients with systemic lupus erythematosus

Evaluation of a telemedicine approach in the care of patients with systemic lupus erythematosus - Evaluation of a telemedicine approach in the care of patients with systemic lupus erythematosus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044870
Enrollment
30
Registered
2021-08-01
Start date
2021-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic lupus erythematosus (SLE)

Interventions

The telemedicine system will be YaDoc, an online medical system from Integrity Healthcare. Patients will install and use the systemic lupus erythematosus symptom management program (application name &
YaDoc&quot
) on their smartphones. Online medical care will be conducted at 8 weeks and 24 weeks after the start of the study. Face-to-face medical care will be conducted at 16 and 32 weeks. Patients will be as

Sponsors

Nagasaki University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients must meet all of the following requirements to be considered for entry into the study: 1. Patients with SLE under treatment at Nagasaki University 2. Patients >=20 years old 3. Not concurrent use of a corticosteroid equivalent to >10 mg/day of prednisolone 4. SLEDAI less than 5 5. Patients without active organ legions 6. Patients or a family member has a smartphone 7. Ability and willingness to provide written informed consent and comply with the requirements of the study protocol

Exclusion criteria

Exclusion criteria: The exclusion criteria are as follows: (1) Patients who are unable or unwilling to use the required online medical system. (2) Inappropriateness for inclusion in this study as determined by the .

Design outcomes

Primary

MeasureTime frame
Contents of "Questionnaire on satisfaction with and issues related to telemedicine systems (for patients)"

Countries

Japan

Contacts

Public ContactToshimasa Shimizu

Nagasaki University Graduate School of Biomedical Sciences Department of Immunology and Rheumatology

t.shimizu@nagasaki-u.ac.jp095-819-7262

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026